Leaflet TETIG 500 500UI solution for injection


Indicated for: prevention of tetanus

Route of administration: injectable

Substance: tetanus immunoglobulin (immunoglobulin)

ATC: J06BB02 (Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins)

Tetanus immunoglobulin is a plasma-derived product used to prevent tetanus in individuals exposed to Clostridium tetani bacteria, usually through contaminated wounds. It provides passive immunity by supplying pre-formed antibodies against the tetanus toxin.

The medication is administered via intramuscular injection, as directed by a doctor.

Side effects may include pain at the injection site, fever, or allergic reactions. In rare cases, anaphylactic reactions may occur.

Patients should inform their doctor about any known allergies or other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about TETIG 500 500UI

  • Substance: tetanus immunoglobulin
  • Date of last drug list: 01-07-2013
  • Commercial code: W53120001
  • Concentration: 500UI
  • Pharmaceutical form: solution for injection
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Pharmaceutical forms available for tetanus immunoglobulin

Concentrations available for tetanus immunoglobulin

  • 250UI/ml
  • 500UI